Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
Westat · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA) · NCT06444360
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 16–24 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 360
- US sites recruiting
- 2
- Study start
- November 4, 2025
- Record last updated
- June 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Being studied: IMPACT; eSOC
Conditions: HIV
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 16-24 years, inclusive, at enrollment
- Male or female
- Self-reports condomless anal or vaginal sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)
- Willing and able to provide written informed consent for study participation
- Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)
- Provide a mailing address where they can receive a package
- Access to stable internet that they can use for more than 2 hours at a time
- Have a private place (where no one else can see or hear) where they can complete visits online
- Reside within the continental U.S.
Exclusion Criteria
- Unable to provide informed consent due to severe mental or physical illness
- Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
- Randomized to IMPACT arm prior to March 2025 study stop
- Non-English-speaking
- Is currently incarcerated or pending incarceration
- Is currently pregnant or planning to become pregnant
- Any other medical condition, medical/behavioral intervention, or other condition that, in the opinion of the Project Lead or designee, could interfere with the safety of participants or staff, adherence to study procedures, or compromise interpretation of study results
Recruiting US locations
University of California, Los Angeles
Los Angeles, CA 90095
Site contact: IMPACT 170 Staff · 310-825-3094 · impactstudy@ph.ucla.edu
Brown University
Providence, RI 02912
Site contact: IMPACT 170 Staff · 401-863-3292 · impact170@brown.edu
Study contacts (from the official record)
- Erin Ricketts · 240-453-2786 · erinricketts@westat.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55